Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor wi... Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Mehr anzeigen
Carlsbad, CA, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
Carlsbad, CA, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.09 | -38.2456140351 | 2.85 | 3.3 | 1.59 | 14365833 | 2.33150654 | CS |
| 4 | -0.83 | -32.0463320463 | 2.59 | 3.3 | 1.38 | 3692577 | 2.31572436 | CS |
| 12 | -1.61 | -47.7744807122 | 3.37 | 4.318 | 1.38 | 1309632 | 2.35313223 | CS |
| 26 | -2.89 | -62.1505376344 | 4.65 | 5.15 | 1.38 | 651254 | 2.43518783 | CS |
| 52 | -6.8335 | -79.5194042008 | 8.5935 | 22.35 | 1.38 | 1282081 | 8.87224743 | CS |
| 156 | -1385.74 | -99.8731531532 | 1387.5 | 1402.425 | 1.38 | 1922679 | 128.83279395 | CS |
| 260 | -6748.24 | -99.9739259259 | 6750 | 8182.5 | 1.38 | 1708889 | 334.72975294 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
